Two matrix metalloproteinases inhibitors from Ferula persica var. persica

A R Shahverdi1, F Saadat, M R Khorramizadeh

  • 1Department of Pharmaceutical Biotechnology and Medicinal Plant Research Center, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran. shahverd@sina.tums.ac.ir

Insights

Ferula persica root extract selectively inhibits tumor cell invasion by reducing matrix metalloproteinases (MMPs). Two isolated compounds, persicasulphide B and umbelliprenin, show potent MMP inhibitory effects, suggesting potential anti-cancer applications.

Area of Science:

  • Pharmacology
  • Natural Products Chemistry
  • Cancer Biology

Background:

  • Matrix metalloproteinases (MMPs) are implicated in tumor invasion and inflammatory diseases.
  • Targeting MMPs is a therapeutic strategy for various pathologies, including cancer.

Purpose of the Study:

  • To investigate the anti-MMP activity of Ferula persica var. persica root extract.
  • To identify bioactive compounds from the extract with MMP inhibitory potential.

Main Methods:

  • In vitro cytotoxicity assay using a fibrosarcoma cell line.
  • Sodium dodecyl sulfate-polyacrylamide and gelatin zymography to assess MMP production.
  • Bioactivity-guided fractionation and spectroscopic methods for compound identification.

Main Results:

  • The Ferula persica root extract demonstrated selective inhibition of tumor cell invasion.
  • Two compounds, persicasulphide B and umbelliprenin, were isolated and exhibited significant MMP inhibitory effects.
  • These active compounds showed maximum efficacy at low, non-toxic concentrations.

Conclusions:

  • Ferula persica var. persica exhibits anti-MMP activity, with potential for developing anti-cancer therapeutics.
  • Persicasulphide B and umbelliprenin are promising candidates for anti-MMP drug development.
  • Further research into these compounds could lead to novel therapeutic derivatives.